Form D · Other Health Care
Protaryx Medical Inc.
Baltimore, MD · CIK 0001815905
Offering snapshot reported Jun 30, 2020 · SEC filing
- Reported sold
- $8.11M Offering amount: $8.11M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 15, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 30, 2020 | Initial | $8,112,668 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-369941
$3,012,668 of the offering was paid for via the conversion of convertible notes.
Source: Form D, filed Jun 30, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Terri Burke | Director, Executive |
| James Gammie | Director |
| Aftab Kherani | Director |
| Duke Rohlen | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
323 West Camden Street Suite 600
Baltimore, MD, 21201
Baltimore, MD, 21201